A new antibiotic to fight the deadly "superbug" C. diff has proved effective in clinical trials. Treating patients with ibezapolstat provided high rates of "sustained" clinical cures, say American ...

EAR DR. ROACH: About one year ago, I had Clostridioides difficile (C. diff) that was treated with 125 mg of vancomycin for about four weeks. I had none of the usual risk factors, and the cause was ...

Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile —commonly known as C. diff —are a serious and persistent problem for patients and ...

Researchers at Tufts University School of Medicine are studying C. diff at multiple levels, from how individual bacterial ...

Matthew Munneke, left, and Eric Skaar, PhD, MPH, use anaerobic chambers to study bacteria like C. diff that die in the presence of oxygen. The pathogen C. diff — the most common cause of health ...

Dear Dr. Roach: About one year ago, I had Clostridioides difficile (C. diff) that was treated with 125 mg of vancomycin for about four weeks. I had none of the usual risk factors, and the cause was ...

A new antibiotic to fight the deadly "superbug" C. diff has proved effective in clinical trials. Rates of C. diff in the UK have increased every year since 2021, reaching 29.5 cases per 100,000 ...

DEAR DR. ROACH: About one year ago, I had Clostridioides difficile (C. diff) that was treated with 125 mg of vancomycin for about four weeks. I had none of the usual risk factors, and the cause was ...